Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
Related Articles

Click here to return to the article.

• 

  These 5 misconceptions about China’s slowing economy could lead to complacency in the U.S., expert warns
  Fortune - 2024-04-07T21:00:00.000Z

• 

  $1 million homes are now 'typical' in a record number of U.S. cities, analysis finds. Here’s where they are
  CNBC - 2024-04-09T13:00:01.000Z

• 

  Tycoon’s death penalty in $12.5 billion fraud case highlights Vietnam’s corruption crisis
  KIFI - 2024-04-13T01:41:53.000Z

• 

  Tycoon’s death penalty in $12.5 billion fraud case highlights Vietnam’s corruption crisis
  KTVZ - 2024-04-13T01:41:53.000Z

• 

  Tycoon’s death penalty in $12.5 billion fraud case highlights Vietnam’s corruption crisis
  CNN - 2024-04-13T01:41:14.773Z

• 

  Tycoon’s death penalty in $12.5 billion fraud case highlights Vietnam’s corruption crisis
  KEYT - 2024-04-13T01:41:14.000Z